Literature DB >> 24838616

Rats with mild bile duct ligation show hepatic encephalopathy with cognitive and motor impairment in the absence of cirrhosis: effects of alcohol ingestion.

Carla Giménez-Garzó1, Dounia Salhi, Amparo Urios, Amparo Ruíz-Sauri, Carmen Carda, Carmina Montoliu, Vicente Felipo.   

Abstract

Studies in animal models allow identifying mechanisms and treatments for cognitive and motor alterations in hepatic encephalopathy (HE). Liver diseases leading to HE in humans have different aetiologies (alcoholic, viral, etc.). The International Society for Hepatic Encephalopathy points out that satisfactory model for HE resulting from alcoholic cirrhosis are lacking. This work aimed to develop and characterize an animal model for HE in alcoholic liver cirrhosis. To potentiate the effects of alcohol on liver we administered it (5, 8 or 10% in drinking water) to rats showing mild liver damage induced by "mild" bile duct ligation (MBDL), obtained by sectioning 3 out of 5 bile ducts. MBDL rats show increased markers of cholestasis and liver damage, hyperammonemia and inflammation. MBDL rats also show motor in-coordination, hypokinesia, impaired learning ability in a Y maze and reduced spatial memory in the Morris water maze. Ingesting 10% ethanol does not induce relevant liver damage in control rats but potentiates liver damage in MBDL rats. In contrast, ethanol did not enhance the biochemical or neurological alterations in MBDL rats. This supports that the combination of certain levels of hyperammonemia and inflammation is enough to induce mild cognitive impairment, even in the absence of liver cirrhosis. Rats with MBDL and MBDL-OH survived more than 3 months, allowing performing long-term studies on cognitive and motor alterations and on underlying mechanisms. MBDL-OH rats are a good model to study the mechanisms of ethanol-induced liver cirrhosis and the factors making the liver susceptible to ethanol damage.

Entities:  

Mesh:

Year:  2014        PMID: 24838616     DOI: 10.1007/s11064-014-1330-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests.

Authors:  Vicente Felipo; Juan F Ordoño; Amparo Urios; Nisrin El Mlili; Carla Giménez-Garzó; Carolina Aguado; Olga González-Lopez; Remedios Giner-Duran; Miguel A Serra; Abdallah Wassel; Jose M Rodrigo; José Salazar; Carmina Montoliu
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

3.  Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats.

Authors:  M A Aguilar; J Miñarro; V Felipo
Journal:  Exp Neurol       Date:  2000-02       Impact factor: 5.330

4.  Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts.

Authors:  Slaven Erceg; Pilar Monfort; Mariluz Hernández-Viadel; Regina Rodrigo; Carmina Montoliu; Vicente Felipo
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

5.  Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.

Authors:  Omar Cauli; Marta Llansola; Slaven Erceg; Vicente Felipo
Journal:  J Hepatol       Date:  2006-08-10       Impact factor: 25.083

6.  Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability.

Authors:  Pilar Monfort; Slaven Erceg; Blanca Piedrafita; Marta Llansola; Vicente Felipo
Journal:  Eur J Neurosci       Date:  2007-04       Impact factor: 3.386

Review 7.  Attention, memory, and cognitive function in hepatic encephalopathy.

Authors:  Karin Weissenborn; Kathrin Giewekemeyer; Susanne Heidenreich; Martin Bokemeyer; Georg Berding; Björn Ahl
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

8.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.

Authors:  Omar Cauli; Regina Rodrigo; Blanca Piedrafita; Jordi Boix; Vicente Felipo
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

10.  Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy.

Authors:  Carroll B Leevy; James A Phillips
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

View more
  5 in total

1.  The Effect of NeuroAid (MLC901) on Cholestasis-Induced Spatial Memory Impairment with Respect to the Expression of BAX, BCL-2, BAD, PGC-1α and TFAM Genes in the Hippocampus of Male Wistar Rats.

Authors:  Pejman Molaei; Salar Vaseghi; Maliheh Entezari; Mehrdad Hashemi; Mohammad Nasehi
Journal:  Neurochem Res       Date:  2021-05-24       Impact factor: 3.996

2.  Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction.

Authors:  Ji Heun Jeong; Do Kyung Kim; Nam-Seob Lee; Young-Gil Jeong; Ho Won Kim; Jong-Seok Kim; Seung-Yun Han
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

3.  Hepatoprotective effect of sodium hydrosulfide on hepatic encephalopathy in rats.

Authors:  Kyoung Wan Kwon; Yoonjin Nam; Won Seok Choi; Tae Wook Kim; Geon Min Kim; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2019-06-25       Impact factor: 2.016

4.  Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation model.

Authors:  Yoonjin Nam; Sung Kwon Ko; Uy Dong Sohn
Journal:  J Ginseng Res       Date:  2018-08-10       Impact factor: 6.060

5.  Hepatic Encephalopathy-Associated Cerebral Vasculopathy in Acute-on-Chronic Liver Failure: Alterations on Endothelial Factor Release and Influence on Cerebrovascular Function.

Authors:  Laura Caracuel; Esther Sastre; María Callejo; Raquel Rodrigues-Díez; Ana B García-Redondo; Isabel Prieto; Carlos Nieto; Mercedes Salaices; Ma Ángeles Aller; Jaime Arias; Javier Blanco-Rivero
Journal:  Front Physiol       Date:  2020-11-20       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.